
Synthetic Genomics Stock
Synthetic Genomics develops genomic-driven solutions to address global energy and environmental challenges.
Sign up today and learn more about Synthetic Genomics Stock
Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.
About Synthetic Genomics Stock
Synthetic Genomics, Inc. develops and commercializes genomic-driven solutions to address global energy and environmental challenges. The company engages in synthesizing and programming DNA by developing and utilizing the technologies in synthetic genomics. It designs and develops microbes for industrial processes and environmental applications. The company also develops microbial cultivation technologies and monitoring approaches that reveal novel microorganisms, suites of new genes, and fermentation platforms for metabolic engineering of microbes for commercial bioenergy applications. In addition, it involves in designing advanced biofuels with properties compared to ethanol and biodiesel; harnessing photosynthetic organisms to produce value added products directly from sunlight and carbon dioxide; developing new biological solutions to enhance production and/or recovery rates of subsurface hydrocarbons; and developing high-yielding, disease resistant, and economic feedstocks. The company's solutions help in improving the production of energy, chemicals, and pharmaceuticals, as well as enable carbon sequestration and environmental remediation. Synthetic Genomics, Inc. was founded in 2005 and is based in La Jolla, California.
Funding History
December 2005 | $30.0M |
---|---|
October 2011 | $0 |
February 2013 | $10.0M |
Management
Co - Founder
Juan Enriquez
Founder & CEO
J. Venter
Co - Founder & Board of Directors
David C. Kiernan
CTO
Jim Flatt
Co - Founder & Co - Chief Scientific Officer
Hamilton Smith
Principal Scientist, Foods Program
Michele Champagne
CFO
Joseph Mahler
VP, Bioinformatics
Toby Richardson
Science Consultant
James Ferry
SVP, Business Development
Fernanda Gandara
Press
Fast Company - Apr, 17 2018
This Machine Sends Vaccines Like They’re A FaxFast Company - Mar, 6 2018
Exxon Thinks It Can Create Biofuel From Algae At Massive ScaleTechCrunch - May, 30 2011
Algae Biofuels Maker Solazyme Goes Public, Finally, Raking In $197.6 MillionEquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase